Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

REAX vs WELL

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
REAX
The Real Brokerage Inc.

Real Estate - Services

Real EstateNASDAQ • CA
Market Cap$436M
5Y Perf.+449.9%
WELL
Welltower Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$150.14B
5Y Perf.+314.1%

REAX vs WELL — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
REAX logoREAX
WELL logoWELL
IndustryReal Estate - ServicesREIT - Healthcare Facilities
Market Cap$436M$150.14B
Revenue (TTM)$1.97B$11.63B
Net Income (TTM)$-8M$1.43B
Gross Margin8.4%39.1%
Operating Margin-0.4%4.4%
Forward P/E78.9x
Total Debt$0.00$21.38B
Cash & Equiv.$60M$5.03B

REAX vs WELLLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

REAX
WELL
StockJun 20May 26Return
The Real Brokerage … (REAX)100549.9+449.9%
Welltower Inc. (WELL)100414.1+314.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: REAX vs WELL

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: WELL leads in 5 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. The Real Brokerage Inc. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
REAX
The Real Brokerage Inc.
The Real Estate Income Play

REAX is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 55.7%, EPS growth 73.6%, 3Y rev CAGR 72.8%
  • 338.1% 10Y total return vs WELL's 230.2%
  • 55.7% FFO/revenue growth vs WELL's 35.8%
Best for: growth exposure and long-term compounding
WELL
Welltower Inc.
The Real Estate Income Play

WELL carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 2 yrs, beta 0.13, yield 1.3%
  • Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
  • Beta 0.13, yield 1.3%, current ratio 5.34x
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthREAX logoREAX55.7% FFO/revenue growth vs WELL's 35.8%
ValueREAX logoREAXBetter valuation composite
Quality / MarginsWELL logoWELL12.3% margin vs REAX's -0.4%
Stability / SafetyWELL logoWELLBeta 0.13 vs REAX's 1.60
DividendsWELL logoWELL1.3% yield; 2-year raise streak; the other pay no meaningful dividend
Momentum (1Y)WELL logoWELL+43.9% vs REAX's -51.1%
Efficiency (ROA)WELL logoWELL2.3% ROA vs REAX's -6.2%, ROIC 0.5% vs -15.9%

REAX vs WELL — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

REAXThe Real Brokerage Inc.

Segment breakdown not available.

WELLWelltower Inc.
FY 2025
Senior Housing - Operating
81.1%$8.5B
Triple Net
11.4%$1.2B
Outpatient Medical
7.5%$782M

REAX vs WELL — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLWELLLAGGINGREAX

Income & Cash Flow (Last 12 Months)

WELL leads this category, winning 4 of 6 comparable metrics.

WELL is the larger business by revenue, generating $11.6B annually — 5.9x REAX's $2.0B. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to REAX's -0.4%. On growth, REAX holds the edge at +44.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricREAX logoREAXThe Real Brokerag…WELL logoWELLWelltower Inc.
RevenueTrailing 12 months$2.0B$11.6B
EBITDAEarnings before interest/tax-$7M$2.8B
Net IncomeAfter-tax profit-$8M$1.4B
Free Cash FlowCash after capex$74M$2.5B
Gross MarginGross profit ÷ Revenue+8.4%+39.1%
Operating MarginEBIT ÷ Revenue-0.4%+4.4%
Net MarginNet income ÷ Revenue-0.4%+12.3%
FCF MarginFCF ÷ Revenue+3.8%+21.9%
Rev. Growth (YoY)Latest quarter vs prior year+44.1%+40.3%
EPS Growth (YoY)Latest quarter vs prior year+42.4%+22.5%
WELL leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

REAX leads this category, winning 3 of 4 comparable metrics.
MetricREAX logoREAXThe Real Brokerag…WELL logoWELLWelltower Inc.
Market CapShares × price$436M$150.1B
Enterprise ValueMkt cap + debt − cash$376M$166.5B
Trailing P/EPrice ÷ TTM EPS-55.28x154.17x
Forward P/EPrice ÷ next-FY EPS est.78.89x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple66.76x
Price / SalesMarket cap ÷ Revenue0.22x14.08x
Price / BookPrice ÷ Book value/share8.70x3.37x
Price / FCFMarket cap ÷ FCF6.72x52.72x
REAX leads this category, winning 3 of 4 comparable metrics.

Profitability & Efficiency

WELL leads this category, winning 6 of 8 comparable metrics.

WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-17 for REAX. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs REAX's 5/9, reflecting strong financial health.

MetricREAX logoREAXThe Real Brokerag…WELL logoWELLWelltower Inc.
ROE (TTM)Return on equity-17.4%+3.5%
ROA (TTM)Return on assets-6.2%+2.3%
ROICReturn on invested capital-15.9%+0.5%
ROCEReturn on capital employed-20.3%+0.6%
Piotroski ScoreFundamental quality 0–957
Debt / EquityFinancial leverage0.49x
Net DebtTotal debt minus cash-$60M$16.3B
Cash & Equiv.Liquid assets$60M$5.0B
Total DebtShort + long-term debt$0$21.4B
Interest CoverageEBIT ÷ Interest expense-15.34x0.26x
WELL leads this category, winning 6 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

WELL leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in WELL five years ago would be worth $31,264 today (with dividends reinvested), compared to $10,851 for REAX. Over the past 12 months, WELL leads with a +43.9% total return vs REAX's -51.1%. The 3-year compound annual growth rate (CAGR) favors WELL at 41.3% vs REAX's 18.7% — a key indicator of consistent wealth creation.

MetricREAX logoREAXThe Real Brokerag…WELL logoWELLWelltower Inc.
YTD ReturnYear-to-date-44.7%+15.0%
1-Year ReturnPast 12 months-51.1%+43.9%
3-Year ReturnCumulative with dividends+67.2%+182.2%
5-Year ReturnCumulative with dividends+8.5%+212.6%
10-Year ReturnCumulative with dividends+338.1%+230.2%
CAGR (3Y)Annualised 3-year return+18.7%+41.3%
WELL leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

WELL leads this category, winning 2 of 2 comparable metrics.

WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than REAX's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 97.6% from its 52-week high vs REAX's 37.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricREAX logoREAXThe Real Brokerag…WELL logoWELLWelltower Inc.
Beta (5Y)Sensitivity to S&P 5001.60x0.13x
52-Week HighHighest price in past year$5.41$219.59
52-Week LowLowest price in past year$1.92$142.65
% of 52W HighCurrent price vs 52-week peak+37.7%+97.6%
RSI (14)Momentum oscillator 0–10036.162.6
Avg Volume (50D)Average daily shares traded2.1M2.6M
WELL leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates REAX as "Buy" and WELL as "Buy". Consensus price targets imply 108.3% upside for REAX (target: $4) vs 5.7% for WELL (target: $227). WELL is the only dividend payer here at 1.29% yield — a key consideration for income-focused portfolios.

MetricREAX logoREAXThe Real Brokerag…WELL logoWELLWelltower Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$4.25$226.50
# AnalystsCovering analysts734
Dividend YieldAnnual dividend ÷ price+1.3%
Dividend StreakConsecutive years of raises2
Dividend / ShareAnnual DPS$2.76
Buyback YieldShare repurchases ÷ mkt cap+9.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

WELL leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). REAX leads in 1 (Valuation Metrics).

Best OverallWelltower Inc. (WELL)Leads 4 of 6 categories
Loading custom metrics...

REAX vs WELL: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is REAX or WELL a better buy right now?

For growth investors, The Real Brokerage Inc.

(REAX) is the stronger pick with 55. 7% revenue growth year-over-year, versus 35. 8% for Welltower Inc. (WELL). Welltower Inc. (WELL) offers the better valuation at 154. 2x trailing P/E (78. 9x forward), making it the more compelling value choice. Analysts rate The Real Brokerage Inc. (REAX) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — REAX or WELL?

Over the past 5 years, Welltower Inc.

(WELL) delivered a total return of +212. 6%, compared to +8. 5% for The Real Brokerage Inc. (REAX). Over 10 years, the gap is even starker: REAX returned +338. 1% versus WELL's +230. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — REAX or WELL?

By beta (market sensitivity over 5 years), Welltower Inc.

(WELL) is the lower-risk stock at 0. 13β versus The Real Brokerage Inc. 's 1. 60β — meaning REAX is approximately 1105% more volatile than WELL relative to the S&P 500.

04

Which is growing faster — REAX or WELL?

By revenue growth (latest reported year), The Real Brokerage Inc.

(REAX) is pulling ahead at 55. 7% versus 35. 8% for Welltower Inc. (WELL). On earnings-per-share growth, the picture is similar: The Real Brokerage Inc. grew EPS 73. 6% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, REAX leads at 72. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — REAX or WELL?

Welltower Inc.

(WELL) is the more profitable company, earning 8. 8% net margin versus -0. 4% for The Real Brokerage Inc. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WELL leads at 3. 3% versus -0. 4% for REAX. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is REAX or WELL more undervalued right now?

Analyst consensus price targets imply the most upside for REAX: 108.

3% to $4. 25.

07

Which pays a better dividend — REAX or WELL?

In this comparison, WELL (1.

3% yield) pays a dividend. REAX does not pay a meaningful dividend and should not be held primarily for income.

08

Is REAX or WELL better for a retirement portfolio?

For long-horizon retirement investors, Welltower Inc.

(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +230. 2% 10Y return). The Real Brokerage Inc. (REAX) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (WELL: +230. 2%, REAX: +338. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between REAX and WELL?

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

WELL pays a dividend while REAX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

REAX

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 22%
Run This Screen
Stocks Like

WELL

High-Growth Compounder

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 20%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform REAX and WELL on the metrics below

Revenue Growth>
%
(REAX: 44.1% · WELL: 40.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.